Article info
PDFMovement disorders
Research paper
Dopamine dysregulation syndrome in Parkinson's disease: from clinical and neuropsychological characterisation to management and long-term outcome
- Correspondence to Dr Roberto Cilia, Parkinson Institute, Istituti Clinici di Perfezionamento, via Bignami 1, Milan 20126, Italy; roberto.cilia{at}gmail.com, roberto.cilia{at}icp.mi.it
Citation
Dopamine dysregulation syndrome in Parkinson's disease: from clinical and neuropsychological characterisation to management and long-term outcome
Publication history
- Received August 22, 2012
- Revised January 29, 2013
- Accepted March 11, 2013
- First published April 16, 2013.
Online issue publication
December 15, 2016
Article Versions
- Previous version (15 December 2016).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Files in this Data Supplement:
- Data supplement 1 - Online figure
- Data supplement 2 - Online table
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions